Originally Published MX January/February 2005
BUSINESS DRIVERS
Business Drivers |
| Feigal |
Former director of the FDA Center for Devices and Radiological Health (CDRH) David W. Feigal Jr., MD, has been named to the board of directors of Aspect Medical Systems Inc. (Newton, MA). Feigal spent 12 years at FDA, where he served in director-level positions for CDRH, the Center for Biologics Evaluation and Research, and the Center for Drug Evaluation and Research. In 2004, Feigal joined NDA Partners LLP (Falls Church, VA) where he advises midstage device and biopharmaceutical companies about clinical and regulatory strategies, product development and design, and the introduction of innovative technologies. Aspect's bispectral index (BIS) technology is widely used to measure the effects of anesthetics and sedatives on the brain.
 |
| Florence |
Novasys Medical Inc. (Newark, CA), a developer of new technologies and therapies for the treatment of female pelvic disorders, has announced the hire of three senior executives. "Strategic expansion of our management team is pivotal at this time, as we prepare to commercialize the Novasys system for the treatment of female stress urinary incontinence," said Debra Reisenthel, Novasys president and CEO. James Berman was named vice president of sales. Berman previously held a variety of positions at NuVasive, including vice president of sales, and also held key positions at Oratec Interventions. Karl Florence was named vice president of reimbursement. His experience includes a wide variety of reimbursement, managed-care, and sales positions at such companies as MiniMed, Cutter Medical, and AVI. He most recently served as director of strategic reimbursement for Conceptus, a leading medical device company in the field of women's health and gynecology. Nancy Westcott was named chief financial officer. Experienced in both public and private healthcare companies, she previously served as CFO and vice president of finance and administration at Arcturus Bioscience, where she was instrumental in helping the company raise $23 million in private equity and debt financing. Westcott also served as CFO and vice president of administration for Oratec Interventions, where she co-led the company through an IPO and successful sale to Smith & Nephew.
 |
| DiNello |
OmniSonics Medical Technologies Inc. (Wilmington, MA) has appointed Alexandre M. DiNello to the position of vice president for research and development and operations. DiNello holds a master's degree in biomedical engineering from the University of Virginia and an MBA from Case Western University. He was previously vice president for strategic development and research and development at DePuy Spine, a Johnson & Johnson company. DiNello holds 11 patents and has two patents pending. OmniSonics is a privately held medical device company that is developing its proprietary OmniWave technology for resolving peripheral and coronary vascular occlusions.
 |
| Huey |
 |
| Horn |
At the annual distributors' meeting of Z-Medica LLC (Newington, CT), company founders Francis X. Hursey and Bart Gullong introduced new leadership for the company. Raymond J. Huey was named chief executive officer, and Jeffrey L. Horn was named chief operating officer. Hursey retains the role of president. The additions are a response to rapid adoption during 2004 of the firm's breakthrough hemostatic product, QuikClot, which resulted in a 400% increase in revenues over 2003. An engineer by training, Huey will be responsible for setting the company's strategic direction, expanding the company's product line for in-hospital use, and putting in place world-class processes to accommodate growth. Horn began his career as a nuclear design engineer, and has spent subsequent years in the biochemical and medical instrumentation fields. He will be responsible for developing global business opportunities and relationships, and for delivering on the company's vision and mission.
Copyright ©2005 MX
